Acarbose Use and Liver Injury in Diabetic Patients With Severe Renal Insufficiency and Hepatic Diseases: A Propensity Score-Matched Cohort Study

Background: Acarbose has been deemed contraindicated in diabetic patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD), but such use is not uncommon. We tested whether this concept hold true in this population with different background hepatic diseases. Methods: All incident d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Chia-Ter, Wang, Jui, Huang, Jenq-Wen, Chien, Kuo-Liong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090209/
https://www.ncbi.nlm.nih.gov/pubmed/30131698
http://dx.doi.org/10.3389/fphar.2018.00860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090209/
https://www.ncbi.nlm.nih.gov/pubmed/30131698
http://dx.doi.org/10.3389/fphar.2018.00860

Ejemplares similares